| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |